Trevi Therapeutics - 53 Year Dividend History | TRVI
Historical dividend payout and yield for Trevi Therapeutics (TRVI) since 1971. The current TTM dividend payout for Trevi Therapeutics (TRVI) as of November 01, 2024 is $0.00. The current dividend yield for Trevi Therapeutics as of November 01, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.219B |
$0.000B |
|
Trevi Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. The company is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis and levodopa-induced dyskinesia in patients with Parkinson's disease. Trevi Therapeutics Inc. is based in New Haven, Connecticut.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
